Strength
4.1 meq/g
Manufacturer
Chartwell RX LLCNDC
62135034053
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL; RECTAL
Last Updated
4/22/2026
Active Ingredients
SODIUM POLYSTYRENE SULFONATEApproval Type
Generic (ANDA)
FDA Application
ANDA206815On Market Since
2/18/2016
Related Drugs
Same classification
No related drugs found.